We had the pleasure of meeting with Dr Óscar González Fernández (La Paz University Hospital, Madrid, Spain) to discuss the risk factors for heart failure in patients with HIV and drug-drug interactions for patients on HIV medication.
The presentation entitled: ‘Heart failure, new drugs, DDIs’ was presented at the 18th European AIDS Conference (EACS 2021), 27-30 October, 2021
- What are the risk factors for heart failure (HF) in patients with HIV? (0:25)
- What are the current recommended treatment approaches and what are the limitations of this? (1:29)
- What are the most common drug-drug interactions for patients on HIV medication? (2:09)
- What do you see as key to rethinking our approach to therapeutic strategies for patients with HIV and HF? (3:06)
Disclosures: Óscar González Fernández has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of EACS (Hybrid) Conference 2021
Share this Video
Related Videos In HIV
Updated HIV primary care guidelines: Mamta Jain, ACTHIV 2023
Updated HIV primary care guidelines provide evidence-based and standardized approaches to manage individuals living with HIV, addressing their unique needs and challenges. By following these guidelines, healthcare providers can enhance patient outcomes and stay abreast of the latest research and treatment advancements in HIV care. In this interview, we speak with Dr Mamta Jain (UT […]
Managing liver complications and drug-drug interactions in HBV-HIV co-infection: ACTHIV 2023 with Jessie Torgersen
Liver complications and drug-drug interactions in HBV viremia in HIV patients are common, so it is important to consider complications and follow appropriate guidelines for patients when prescribing treatment. In this interview, we speak with Dr Jessie Torgersen (University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA) to explore considerations for healthcare professionals, including liver complications […]
HIV-HBV co-infection screening and monitoring guidelines: ACTHIV 2023, Jessie Torgersen
Screening and managing HIV-hepatitis B virus (HBV) co-infection is important due to increased risks in patients, therefore it is important to ensure standard practices involve comprehensive assessment, including serological testing and liver function evaluation, and healthcare professionals follow guidelines for regular monitoring to assess disease progression and treatment response. In this interview, we speak with […]